China to Audit Foreign and Domestic Drug Makers on Accounting Compliance

Published date07 June 2019
Subject MatterLife Sciences,China,Audits,Drug Pricing,Pharmaceutical Industry
AuthorTodd Liao
Law FirmMorgan Lewis

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT